Capsule endoscopy in suspected small bowel Crohn’s disease: Economic impact of disease diagnosis and treatment

Table 1 Aggregate charges for each therapeutic grouping used in model

Procedure	Group 1	Group 2	Group 3
Base charge1	$49 074	$13 258	$8295
Monoclonal therapy2	-	$16 250	-
Colon/SBFT3	$50 253	$30 687	$9474
CE4	$50 612	$31 046	$9833

¹Groups 1, 2, and 3 base annual charges adjusted for inflation from Feagan et al by consumer price index (CPI) to estimate 2007 charges;

²Base annual charge for monoclonal (Infliximab) therapy for Crohn’s disease was estimated as $65 000. We assumed 25% of patients requiring aggressive medical management were treated with this agent and adjusted Group 2 by $16 250;

³Colon/SBFT procedure charge $1179;

⁴CE procedure charge $1538. SBFT: Small bowel follow-through; CE: Capsule endoscopy.